ADURO BIOTECH

Patent Applications and Registrations

Patent applications and USPTO patent grants for ADURO BIOTECH.The latest application filed is for "methods and compositions using listeria for enhancing immunogenicity by prime boost".

Company Profile

0.11.10

ADURO BIOTECH - Berkeley CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Engineered Listeria and methods of use thereof Grant 9,764,013 - Dubensky, Jr. , et al. September 19, 2	2017-09-19
Facultatively attenuated bacterial species and methods of preparation and use thereof Grant 9,511,129 - Hanson , et al. December 6, 2	2016-12-06
Methods and compositions for inducing an immune response to EGFRvIII Grant 9,200,057 - Lauer , et al. December 1, 2	2015-12-01
Methods And Compositions Using Listeria For Enhancing Immunogenicity By Prime Boost App 20150125485 - Dubensky, JR.; Thomas W. ; et al.	2015-05-07
Compositions And Methods For Cancer Immunotherapy App 20150010613 - Dubensky, JR.; Thomas W. ; et al.	2015-01-08
Methods and compositions using Listeria for enhancing immunogenicity by prime boost Grant 8,926,993 - Dubensky, Jr. , et al. January 6, 2	2015-01-06
Engineered Listeria And Methods Of Use Thereof App 20140315314 - Dubensky, JR.; Thomas W. ; et al.	2014-10-23
Facultatively Attenuated Bacterial Species And Methods Of Preparation And Use Thereof App 20140127816 - HANSON; William G. ; et al.	2014-05-08
Methods And Compositions For Inducing A T-cell Response To Plasmodium Species App 20130323275 - Lauer; Peter M. ; et al.	2013-12-05
Methods And Compositions Using Listeria For Adjuvant Treatment Of Cancer App 20130315950 - Dubensky; Thomas W. ; et al.	2013-11-28
Engineered Listeria and methods of use thereof Grant 8,580,939 - Dubensky, Jr. , et al. November 12, 2	2013-11-12
Compositions Comprising Prfa* Mutant Listeria And Mehtods Of Use Thereof App 20110287055 - Lauer; Peter M. ; et al.	2011-11-24
Engineered Listeria and methods of use thereof Grant 7,935,804 - Dubensky, Jr. , et al. May 3, 2	2011-05-03
Modified free-living microbes, vaccine compositions and methods of use thereof Grant 7,927,606 - Dubensky, Jr. , et al. April 19, 2	2011-04-19
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof Grant 7,842,289 - Dubensky, Jr. , et al. November 30, 2	2010-11-30
Modified free-living microbes, vaccine compositions and methods of use thereof Grant 7,833,775 - Dubensky, Jr. , et al. November 16, 2	2010-11-16
Magnetic nanoscale particle compositions, and therapeutic methods related thereto Grant 7,731,648 - Ivkov June 8, 2	2010-06-08
Modified free-living microbes, vaccine compositions and methods of use thereof Grant 7,695,725 - Dubensky, Jr. , et al. April 13, 2	2010-04-13
Ligand Conjugated Thermotherapy Susceptors And Methods For Preparing Same App 20090317408 - Ivkov; Robert ; et al.	2009-12-24

Company Registrations

NCAGE Code	5DG86	ADURO BIOTECH
CAGE Code	5DG86	ADURO BIOTECH
DUNS	829985857	Aduro Biotech

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.